- Report
- December 2024
- 305 Pages
Global
From €4699EUR$4,950USD£3,964GBP
- Report
- September 2024
- 152 Pages
Global
From €2136EUR$2,250USD£1,802GBP
- Report
- October 2024
- 189 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 183 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 196 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 195 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- December 2024
- 105 Pages
Global
From €5649EUR$5,950USD£4,765GBP
- Report
- November 2024
- 150 Pages
Global
From €5649EUR$5,950USD£4,765GBP
- Report
- July 2024
- 139 Pages
Global
From €2847EUR$2,999USD£2,402GBP
- Report
- July 2024
- 180 Pages
Global
From €2174EUR$2,290USD£1,834GBP
- Report
- March 2025
- 297 Pages
Global
From €5174EUR$5,450USD£4,364GBP
- Report
- March 2025
- 93 Pages
Global
From €5316EUR$5,600USD£4,484GBP
- Report
- March 2025
- 82 Pages
Global
From €5316EUR$5,600USD£4,484GBP
- Report
- March 2025
- 182 Pages
Global
From €4699EUR$4,950USD£3,964GBP
- Report
- March 2025
- 194 Pages
Global
From €4699EUR$4,950USD£3,964GBP
- Report
- January 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- March 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- February 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- February 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- July 2024
- 100 Pages
Global
From €3560EUR$3,750USD£3,003GBP

The Transcatheter Mitral Valve (TMV) is a type of cardiovascular device used to treat mitral valve regurgitation, a condition in which the mitral valve does not close properly, allowing blood to flow backward into the left atrium. TMV is a minimally invasive procedure that involves the insertion of a prosthetic valve into the heart through a catheter. This procedure is an alternative to open-heart surgery, which is more invasive and carries a higher risk of complications.
TMV is a rapidly growing market, with a number of companies developing and marketing products. These companies are focused on improving the safety and efficacy of TMV procedures, as well as expanding the range of patients who can benefit from the procedure. Companies in the TMV market include Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, and Neovasc. Show Less Read more